Get access to our best features

Get access to our best features

Published 1 year ago

Researchers devise new strategies to overcome a key CRISPR flaw

Summary by Ground News

It took just three years, after the tool's invention, for researchers to devise ways of using CRISPR-Cas9 gene editing to treat mice with Duchenne muscular dystrophy. Since those first 2015 papers, dozens more have been published and multiple startups have launched. Yet, with one exception, no gene-editing treatments have entered the clinic and none appear particularly close.

0 Articles

0 Articles

All

Left

Center

Right

Researchers devise new strategies to overcome a key CRISPR flaw

Looking for treatments for muscular dystrophy, researchers focus on CRISPR's potential for Cas9 to set off the body’s alarms.

1 year ago·Boston, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center1Last Updated1 year agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

STAT

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

Trending Topics

Donate Privacy Policy Manage Cookies Terms and Conditions

© 2024 Snapwise Inc.